drugset
drugset / Trial / NCT00598559

Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients

NCT00598559 ↗

Phase 3 Completed 213 enrolled Mallinckrodt
RandomizedParallel-groupOpen-labelTreatment

Summary

The study will be investigating safety and efficacy administration of repeated dose of IV Acetaminophen (IV APAP) over five days for the treatment of acute pain or fever in adult patients.

Timeline

Start
2008-01
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Intravenous
Subject Acetaminophen Small molecule 1 g Intravenous

Indications

No indication recorded.